Exothera
Antonio Salgado-Somoza, PhD is a Senior Analytical Scientist at Exothera with experience in various scientific roles. Antonio previously worked as a Laboratory Specialist at Spring Professional and as a Scientist at Luxembourg Institute of Health. Prior to that, Antonio was a Postdoctoral Researcher at Maastricht University and a Biologist at IDICHUS. Antonio completed their PhD in Biology, Molecular Medicine from Universidad de Santiago de Compostela.
Exothera
Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing. Company number: 0744643660 VAT: BE0744643660